All Stories

CUBA'S Mambisa vaccine candidate meets study expectations

Havana, Apr 27 (Prensa Latina) Mambisa, Cuba's only anti-Covid-19 vaccine candidate administered nasally, managed to get more than 70 percent of the volunteers participating in the clinical study to increase their antibody titers fourfold, they reported today.

CUBA'S Mambisa vaccine candidate meets study expectations
Please fill the required field.
Image